UNITED THERAPEUTICS Corp Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • UNITED THERAPEUTICS Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $41.7M, a 97.6% increase year-over-year.
  • UNITED THERAPEUTICS Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $134M, a 53% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Share-based Payment Arrangement, Expense for 2023 was $39.1M, a 63.4% decline from 2022.
  • UNITED THERAPEUTICS Corp annual Share-based Payment Arrangement, Expense for 2022 was $107M, a 22.9% decline from 2021.
  • UNITED THERAPEUTICS Corp annual Share-based Payment Arrangement, Expense for 2021 was $139M, a 15.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $39.1M -$67.7M -63.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $107M -$31.7M -22.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $139M -$25.3M -15.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $164M +$118M +261% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $45.4M +$71.8M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$26.4M -$99.9M -136% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $73.5M +$61.4M +507% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $12.1M -$268M -95.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $280M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.